Auszug
In Deutschland leben ca. 4Mio. Männer und Frauen mit Diabetes mellitus, das sind ca. 5% der Bevölkerung. Die Mehrheit aller Diabeteskranken (80–90%) leidet an einem Typ-2-Diabetes. Ab dem 40. Lebensjahr ist er die häufi gste Diabetesform. Die Prävalenz des Diabetes Typ2 steigt bis zum Alter von 80 Jahren deutlich an (von 2% bei 40-Jährigen bis zu über 20% in höheren Lebensaltern).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Blüher M, Hamann A (2008) Adipositas und metabolisches Syndrom. Diabetol Stoffw 1:R1–R18
Corrada MM, Kawas CH, Mozaffar F, Paganini-Hill A (2006) Association of body mass index and weight change with all-cause mortality in the elderly. Am J Epidemiol 163: 938–949
CRESCENDO (Comprehensive Rimonabant Evaluation Study of Cardiovacular END points and Outcomes) Clinical Trials. gov Identifier: NCT00263042 (sanofi-aventis). http://clinicaltrials.gov/ct/show/NCT00263042
Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
Guare JC, Wing RR, Grant A (1995) Comparison of obese NIDDM and nondiabetic women: short-and long-term weight loss. Obesity Res 3:329–335
Icks A, Rathmann W, Rosenbauer J, Giani G (2005) Diabetes mellitus. In. Robert Koch-Insitut Gesundheitsberichterstattung des Bundes 24:7–14
Kramer FM, Jeffery RW, Forster JL, Snell MK (1989) Long-term follow-up of behavioral tratment for obesity: patterns of wieght regain in men and women. Int J Obes Relat Metab Disord 13:123–136
Perri MG (1989) The main tenenace of treatment effects in the long-term management of obesity. Clin Psychol 5: 526–543
Philip W, James T (2005) The SCOUT study: risk-benefit profile of sibutramine in overweight high-risk cardiovascular patients. Eur Heart J 7:L44–L48
Ryan DH, Espeland MA, Foster GD et al, Look AHEAD Research Group (2003) Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 24(5):610–628
Sjöström L, Narbro K, Sjöström CD et al, Swedish Obese Subjects Study (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357(8):741–752
Torgerson JS, Hauptman J, Boldrin MN, Sjöström L (2004) XE-Nical in the prevention of diabetes in obese subjects (XE-NDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27(3):856
Tuomilehto J, Lindström J, Eriksson JG et al, Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343–1350
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
Wadden TA, Foster GD (2000) Behavioral treatment of obesity. Med Clin North Am 84:441–462
Yang D, Fontaine KR, Wang C, Allison DB (2003) Weight loss causes increased mortality: cons. Obesity Rev 4:9–16
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Herpertz, S. (2008). Behandlung der Adipositas bei Diabetes mellitus. In: Herpertz, S., de Zwaan, M., Zipfel, S. (eds) Handbuch Essstörungen und Adipositas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76882-1_58
Download citation
DOI: https://doi.org/10.1007/978-3-540-76882-1_58
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-76881-4
Online ISBN: 978-3-540-76882-1
eBook Packages: Medicine (German Language)